(Q45201798)

English

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

scientific article published in August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression (English)

1 reference

Europe PubMed Central

10 December 2017

0 references

0 references

Tanja D de Gruijl

5

object named as

Tanja D de Gruijl

1 reference

Europe PubMed Central

10 December 2017

Chris J L M Meijer

10

object named as

Chris J L M Meijer

1 reference

Europe PubMed Central

10 December 2017

author name string

Inge S van Houdt

1

1 reference

Europe PubMed Central

10 December 2017

Berbel J R Sluijter

2

1 reference

Europe PubMed Central

10 December 2017

Laura M Moesbergen

3

1 reference

Europe PubMed Central

10 December 2017

Wim M Vos

4

1 reference

Europe PubMed Central

10 December 2017

Barbara G Molenkamp

6

1 reference

Europe PubMed Central

10 December 2017

Alfons J M van den Eertwegh

7

1 reference

Europe PubMed Central

10 December 2017

Erik Hooijberg

8

1 reference

Europe PubMed Central

10 December 2017

Paul A M van Leeuwen

9

1 reference

Europe PubMed Central

10 December 2017

Joost J Oudejans

11

1 reference

Europe PubMed Central

10 December 2017

language of work or name

0 references

publication date

1 August 2008

1 reference

Europe PubMed Central

10 December 2017

International Journal of Cancer

1 reference

Europe PubMed Central

10 December 2017

123

1 reference

Europe PubMed Central

10 December 2017

3

1 reference

Europe PubMed Central

10 December 2017

609-615

1 reference

Europe PubMed Central

10 December 2017

The epidemiology of skin cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Age as a prognostic factor in the malignant melanoma population

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

MHC-I antigen expression determines sensitivity of hematopoetic progenitor cells as targets for NK cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Helping the CD8(+) T-cell response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Presentation of antigens by MHC class II molecules: getting the most out of them

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Genetic complexity and expression of human class II histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Helper T cells, dendritic cells and CTL Immunity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Selective MHC expression in tumours modulates adaptive and innate antitumour responses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Transcriptional regulation of antigen presentation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.23543

21 January 2018

Identifiers

10.1002/IJC.23543

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45201798&oldid=2069776490"